EU regulator recommends dose gap of 3 weeks for Pfizer COVID-19 vaccine

Europe's drugs regulator said on Thursday it now recommended that the second dose of Pfizer's COVID-19 vaccine be given three weeks after the first as many countries delay shots to vaccinate more of their population.

The labeling of the vaccine, developed along with Germany's BioNTech and branded Comirnaty in Europe, before the change stated that the interval between the two doses should be "at least 21 days," the European Medicines Agency said. 

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy